What is ADAPT?

ADAPT (Antitrypsin Deficiency Assessment and Programme for Treatment) has been established by research doctors who have an international reputation for their research
into the causes of emphysema, in collaboration with the pharmaceutical company Bayer.

ADAPT’s mission is to collect information about how AAT deficiency affects you and your family. As well as being helpful to you in understanding the effects of AAT deficiency on
your lungs, this information will be critical to the design of clinical studies.

ADAPT News is an occasional booklet which gives information about the disease, 
research and treatment. Back copies are available from the ADAPT office, contact details below.

The Patient Community

Being a patient under ADAPT means that you meet other patients. There is an alpha-1 “community” in which patients support each other in friendship, sharing information,
supporting research and so on.

Further information can be obtained:

Robert A. Stockley MD, D.Sc ., F.R.C.P.
Professor in Medicine

_________________________________________________________________________

Mrs Rebecca Bray
Project Co-ordinator

_________________________________________________________________________

Dr Anita Pye
Clinical Trials Co-ordinator

_________________________________________________________________________

ADAPT Project
First Floor, Nuffield House
Queen Elizabeth Hospital
BIRMINGHAM
B15 2TH

Telephone: 0121-697-8257
Fax: 0121-697- 8256

_________________________________________________________________________

Alpha-1-Antitrypsin Deficiency finger-prick testing kits are available free of charge from:-

Mrs. Rebecca Bray
ADAPT Project Co-ordinator
1st Floor Nuffield House
Queen Elizabeth Hospital
Birmingham.  B15 2TH UK

Tel no: 0121 697 8257

Email: Rebecca Bray

The details required for the kit to be sent out are your name, address and date of birth and
the name and address of your general practitioner.